Literature DB >> 17382191

Beneficial effect of corticosteroids in catecholamine-dependent septic burn patients.

P Ch Fuchs1, A Bozkurt, D Johnen, R Smeets, A Groger, N Pallua.   

Abstract

Recent studies indicated the benefit of hydrocortisone in septic patients based on the significant reduction of catecholamines and improved outcome in common intensive care patients. The treatment of intensive care burn patients with corticosteroids was discussed with great caution due to the especially compromised immune status of severely burned patients. The purpose of this study was to investigate the influence of corticosteroids in burn patients during septic shock. In our burn unit, we started with the administration of cortisol in 2001. In this retrospective study, 10 severely burned patients received, > or = 24h after norepinephrine dependency, hydrocortisone infusions of 200 mg/24 h. The course of norepinephrine dose, hemodynamic measurements (Swan-Ganz-Catheter) and daily Sequential Organ Failure Assessment (SOFA-Score) were analyzed and compared to nine (catecholamine-dependent) burn patients without cortisol therapy. Statistical analysis by means of Fisher's Exact Test revealed beneficial effects (morbidity and mortality) of low dose cortisol therapy compared to control patients. However, the results of this study must be interpreted with caution because of its limited number of patients and its retrospective character. Further randomized prospective controlled studies are necessary to determine the efficacy and safety of cortisol therapy in burn patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382191     DOI: 10.1016/j.burns.2006.07.026

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  5 in total

Review 1.  New technologies in global burn care - a review of recent advances.

Authors:  Laura Kearney; Eamon C Francis; Anthony Jp Clover
Journal:  Int J Burns Trauma       Date:  2018-08-20

Review 2.  Therapeutic strategies for high-dose vasopressor-dependent shock.

Authors:  Estevão Bassi; Marcelo Park; Luciano Cesar Pontes Azevedo
Journal:  Crit Care Res Pract       Date:  2013-09-15

3.  Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial.

Authors:  Fabienne Venet; Jonathan Plassais; Julien Textoris; Marie-Angélique Cazalis; Alexandre Pachot; Marc Bertin-Maghit; Christophe Magnin; Thomas Rimmelé; Guillaume Monneret; Sylvie Tissot
Journal:  Crit Care       Date:  2015-01-26       Impact factor: 9.097

Review 4.  Clinical review: the critical care management of the burn patient.

Authors:  Jane A Snell; Ne-Hooi W Loh; Tushar Mahambrey; Kayvan Shokrollahi
Journal:  Crit Care       Date:  2013-10-07       Impact factor: 9.097

5.  Blood pressure alterations in burn patients with septic shock under hydro-cortisone treatment.

Authors:  Faranak Alinejad; Mahnoush Momeni; Mohammad Javad Fatemi; Mohsen Saberi; Mahboobeh Sattarzade; Rafat Babajani; Hossein Rahbar
Journal:  Iran J Microbiol       Date:  2015-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.